Newer vaccines coming out next month....
Moderna'''s updated COVID vaccine effective against '''Eris''' variant in humans | Reuters
Pfizer'''s updated COVID shot effective against '''Eris''' variant in mice study | ReutersAug 17 (Reuters) - Moderna (MRNA.O) said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans.
The company expects the updated shot to be available, pending approval from health regulators in the United States, Europe and elsewhere, in the coming weeks for the fall vaccination season.
Moderna and other COVID-19 vaccine makers Novavax (NVAX.O), Pfizer (PFE.N) and German partner BioNTech SE (22UAy.DE) have created versions of their shots aimed at the XBB.1.5 subvariant.
Earlier on Thursday, Pfizer reported that its updated COVID-19 shot, co-developed with BioNTech, showed neutralizing activity against the Eris subvariant in a study conducted on mice.
Eris, the nickname for EG.5, is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant.
EG.5 accounted for about more than 17% of COVID-19 cases in the U.S., according to the latest government data. Infections from Fornax, officially known as FL 1.5.1, are also rising across the country
Aug 17 (Reuters) - Pfizer Inc (PFE.N) said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the "Eris" subvariant in a study conducted on mice.
Pfizer, along with its German partner BioNTech SE (22UAy.DE), as well as other COVID-19 vaccine makers Moderna (MRNA.O) and Novavax (NVAX.O) have created versions of their shots, which are aimed at the XBB.1.5 subvariant.
Last edited by Monseratto; August 18th, 2023 at 11:27 AM.
US CDC tracks new lineage of virus that causes COVID-19
The lineage is named BA.2.86, and has been detected in the United States, Denmark, and Israel, the CDC said in a post on messaging platform X.
“As we learn more about BA.2.86, CDC’s advice on protecting yourself from COVID-19 remains the same,” the agency said.
The World Health Organization (WHO) earlier on Thursday said in a post on X that it had classified BA.2.86 as a “variant under monitoring” due to the large number of mutations it carries.
The WHO said that, so far, only a few sequences of the variant have been reported from a handful of countries.
The new lineage, which has 36 mutations from the currently-dominant XBB.1.5 COVID variant “harkens back to an earlier branch” of the virus, explained Dr. S. Wesley Long, medical director of diagnostic microbiology at Houston Methodist.
He said it remains to be seen whether BA.2.86 will be able to out-compete other strains of the virus or have any advantage in escaping immune responses from prior infection or vaccination.
won't let covid fade no?
gotta keep covid awareness alive
parang isang sakit lang meron sa mundo
PIrola...
Pirola, the new COVID variant, may infect more people than previous strains. Here's what you need to know about it.There is not a lot of information at this point about Pirola symptoms. The Michigan Health Department said in a statement on X that one patient in the state who contracted it has had "mild symptoms" and is currently not in the hospital.
"There's not much clinical information that is known about this," Dr. Thomas Russo, a professor and chief of infectious diseases at the University at Buffalo in New York, tells Yahoo Life. Schaffner says, "It's early days, but we wouldn't expect anything different — all of these variants have the same symptoms."
Schaffner says that "people shouldn't be obsessively concerned about this," adding, "This is what the virus does. It's not a major new variant of concern because it doesn't produce more severe disease."
Russo expects that the fall COVID-19 booster should be able to offer at least some protection against Pirola, as well as Eris — but how much isn't entirely clear right now. "That's why this variant has gotten a little buzz, because it has 36 different mutations," and that distinguishes it from the XBB.1.5 variant, on which the fall vaccine is based. "As a result, it's possible that it may be more immune-evasive."
Doctors stress that the low number of Pirola cases worldwide right now makes it difficult to know if this variant will be an issue. "It's brand new," Schaffner says.
Last edited by Monseratto; August 24th, 2023 at 08:04 PM.
Is China still in the COVID vaccine race? Mukhang the US brands are left, receiving gov't subsidies to update vs newer variants... mukhang wala na si Astrazeneca and J&J.
President Joe Biden says he will request more funding for a new coronavirus vaccinePeople should be able to start rolling up their sleeves next month for what officials hope is an annual fall COVID-19 shot. Pfizer, Moderna and smaller manufacturer Novavax all are brewing doses of the XBB update but the Food and Drug Administration will have to sign off on each, and the U.S. Centers for Disease Control and Prevention must then issue recommendations for their use.
“I signed off this morning on a proposal we have to present to the Congress a request for additional funding for a new vaccine that is necessary, that works,” Biden, who is vacationing in the Lake Tahoe area, told reporters on Friday.
He added that it’s “tentatively” recommended “that everybody get it,” once the shots are ready.